Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 August 2023 | Story NONSINDISO QWABE | Photo SUPPLIED
Apartheid Studies, A Manifesto Book Launch
Prof Nyasha Mboti launched his book, Apartheid Studies: A Manifesto, on the UFS Qwaqwa Campus on 25 July 2023.

in a perpetual state of disaster and creating a normalised life, even if it is built on anomalous arrangements, Prof Nyasha Mboti launched his newly published book, Apartheid Studies: A Manifesto, on the UFS Qwaqwa Campus on 25 July 2023.

Prof Mboti is an Associate Professor and Head of the Department of Communication Science at the University of the Free State and is the pioneer and founder of Apartheid Studies, a new interdisciplinary field of study from the Global South, which utilises the notion of ‘apartheid’ as a paradigm by which to understand the confounding persistence and permanence of harm, oppression, and injustice.

Oppressive systems persist in modern South Africa

Making reference to the pass laws that were a dominant form/tool of oppression and segregation during the country’s apartheid system, he said apartheid created a “paradigm of life where things that aren’t supposed to go on, go on. 
Life has to go on even in oppression. People have the capacity to live with harm, and apartheid banks on people’s capacity to go on”.

The daring book posits itself as a first-of-its-kind authoritative study of the phenomenon of apartheid, shedding light on the continuing impact of apartheid decades after its formal abolishment and exploring the idea that while it was intended as a temporary phenomenon, it became deeply ingrained and normalised, persisting in various forms today.

“What apartheid is, is a temporary phenomenon that has become permanent. That is my argument. This book is an attempt to leverage how we live with harm as a way of doing something about it and hopefully putting an end to it. If you can go on one day living in harm and the next, before you know it, four decades of living under Apartheid from day to day have passed. Until we understand it, it persists,” he said.

By asking whether one would queue for a dompas, Prof Mboti challenged the audience to reflect on how oppressive systems persist when normalised, even when inflicting profound harm. 
“Would you queue for a dompas? If your answer is yes, then for me, that is an indication that Apartheid persists. Harm persists. Until we understand it, it persists.”

News Archive

Science is diversifying the uses of traditional medicines
2017-07-17

Description: Dr Motlalepula Matsabisa  Tags: traditional medicines, Indigenous Knowledge Systems, Dr Motlalepula Matsabisa, Malaria, priority disease  

Dr Motlalepula Matsabisa.
Photo: Anja Aucamp

According to the World Health Organisation, a large majority of the African population are making use of traditional medicines for health, socio-cultural, and economic purposes. In Africa, up to 80% of the population uses traditional medicines for primary healthcare.

The Indigenous Knowledge Systems (IKS) was identified as a lead programme under the directorship of Dr Motlalepula Matsabisa. Research undertaken by the IKS Lead Programme focuses on some key priority diseases of the country and region – including malaria, HIV, cancer, and diabetes.
 
Not just a plant or tree

Malaria is a priority disease and is prevalent in rural and poor areas, resulting in many traditional health practitioners claiming to treat and cure the disease. There may well be substance to these claims, since as much as 30% of the most effective current prescription medicines are derived from plants.  For instance, chloroquine, artemisinin for malaria, Metformin for diabetes, Vincristine and Vinblastine for cancer, are plant-derived drugs.  

Dr Matsabisa’s current research is investigating a South African medicinal plant that has been shown to have in vitro antiplasmodial activity, with subsequent isolation and characterisation of novel non-symmetrical sesquiterpene lactone compounds offering antimalarial activity. These novel compounds are now patented in South Africa and worldwide. This research is part of the UFS and South Africa’s strive to contribute to the regional and continental malaria problem. The UFS are thus far the only university that has been granted a permit by the Medicines Control Council to undertake research on cannabis and its potential health benefits.

“All of these projects are aimed
at adding value through the scientific
research of medicinal plants, which
can be used for treating illnesses,
diseases, and ailments.”

Recognition well deservedThrough Dr Matsabisa’s research input and contributions to the development of the pharmacology of traditional medicines, he recently became the first recipient of the International Prof Tuhinadrin Sen Award from the International Society of Ethnopharmacology (ISE) and the Society of Ethnopharmacology in India. ISE recognises outstanding contributions by researchers, scientists, and technologists in the area of medicinal plant research and ethnopharmacology internationally.

More recently, Dr Matsabisa undertook research projects funded by the National Research Foundation, as well as the Department of Science and Technology, on cancer, gangrene, and diabetes. He is also involved in a community project to develop indigenous teas with the community. He says, “All of these projects are aimed at adding value through the scientific research of medicinal plants, which can be used for treating illnesses, diseases, and ailments”.

Dr Matsabisa has worked with many local and international scientists on a number of research endeavours. He is grateful to his colleagues from the Department of Pharmacology in the Faculty of Health Sciences, who are dedicated to science research and the research of traditional medicines. The IKS unit also received immense support from the Directorate of Research Development.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept